Lifemd Inc Stock Revenue
| LFMD Stock | USD 5.97 0.07 1.19% |
LifeMD Inc fundamentals help investors to digest information that contributes to LifeMD's financial success or failures. It also enables traders to predict the movement of LifeMD Stock. The fundamental analysis module provides a way to measure LifeMD's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to LifeMD stock.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 152.5 M | 160.2 M |
LifeMD | Revenue |
LifeMD Inc Company Revenue Analysis
LifeMD's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current LifeMD Revenue | 152.55 M |
Most of LifeMD's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, LifeMD Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Historical and Projected quarterly revenue of LifeMD
Projected quarterly revenue analysis of LifeMD Inc provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of LifeMD match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in LifeMD's stock price.
LifeMD Revenue Driver Correlations
Understanding the fundamental principles of building solid financial models for LifeMD is extremely important. It helps to project a fair market value of LifeMD Stock properly, considering its historical fundamentals such as Revenue. Since LifeMD's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of LifeMD's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of LifeMD's interrelated accounts and indicators.
| 0.96 | 0.87 | 0.7 | 0.89 | 0.38 | ||
| 0.96 | 0.97 | 0.76 | 0.97 | 0.33 | ||
| 0.87 | 0.97 | 0.77 | 0.99 | 0.23 | ||
| 0.7 | 0.76 | 0.77 | 0.72 | 0.29 | ||
| 0.89 | 0.97 | 0.99 | 0.72 | 0.24 | ||
| 0.38 | 0.33 | 0.23 | 0.29 | 0.24 |
Click cells to compare fundamentals
LifeMD Revenue Historical Pattern
Today, most investors in LifeMD Stock are looking for potential investment opportunities by analyzing not only static indicators but also various LifeMD's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's revenue growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of LifeMD revenue as a starting point in their analysis.
LifeMD Revenue |
| Timeline |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
LifeMD Current Deferred Revenue
Current Deferred Revenue |
|
Based on the latest financial disclosure, LifeMD Inc reported 152.55 M of revenue. This is 98.0% lower than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The revenue for all United States stocks is 98.38% higher than that of the company.
LifeMD Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses LifeMD's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of LifeMD could also be used in its relative valuation, which is a method of valuing LifeMD by comparing valuation metrics of similar companies.LifeMD is currently under evaluation in revenue category among its peers.
LifeMD ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, LifeMD's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to LifeMD's managers, analysts, and investors.Environmental | Governance | Social |
LifeMD Institutional Holders
Institutional Holdings refers to the ownership stake in LifeMD that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of LifeMD's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing LifeMD's value.| Shares | Goldman Sachs Group Inc | 2024-09-30 | 384.4 K | Renaissance Technologies Corp | 2024-09-30 | 351.2 K | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 338.7 K | Northern Trust Corp | 2024-09-30 | 317.3 K | Nuveen Asset Management, Llc | 2024-09-30 | 284 K | Quinn Opportunity Partners Llc | 2024-09-30 | 269 K | Bridgeway Capital Management, Llc | 2024-09-30 | 251.2 K | Deerfield Management Co | 2024-09-30 | 241.3 K | Bank Of New York Mellon Corp | 2024-09-30 | 208.7 K | Blackrock Inc | 2024-06-30 | 2.3 M | Vanguard Group Inc | 2024-09-30 | 1.7 M |
LifeMD Fundamentals
| Return On Equity | -7.82 | ||||
| Return On Asset | -0.21 | ||||
| Profit Margin | (0.12) % | ||||
| Operating Margin | (0.09) % | ||||
| Current Valuation | 229.24 M | ||||
| Shares Outstanding | 43.31 M | ||||
| Shares Owned By Insiders | 15.71 % | ||||
| Shares Owned By Institutions | 40.51 % | ||||
| Number Of Shares Shorted | 5.87 M | ||||
| Price To Book | 107.72 X | ||||
| Price To Sales | 1.32 X | ||||
| Revenue | 152.55 M | ||||
| Gross Profit | 100.37 M | ||||
| EBITDA | (8.21 M) | ||||
| Net Income | (20.6 M) | ||||
| Cash And Equivalents | 5.84 M | ||||
| Cash Per Share | 0.19 X | ||||
| Total Debt | 18.93 M | ||||
| Debt To Equity | 0.46 % | ||||
| Current Ratio | 0.52 X | ||||
| Book Value Per Share | (0.18) X | ||||
| Cash Flow From Operations | 8.82 M | ||||
| Short Ratio | 8.92 X | ||||
| Earnings Per Share | (0.64) X | ||||
| Target Price | 12.0 | ||||
| Number Of Employees | 207 | ||||
| Beta | 1.23 | ||||
| Market Capitalization | 255.54 M | ||||
| Total Asset | 58.48 M | ||||
| Retained Earnings | (214.27 M) | ||||
| Working Capital | 7.82 M | ||||
| Net Asset | 58.48 M |
About LifeMD Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze LifeMD Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of LifeMD using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of LifeMD Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether LifeMD Inc is a strong investment it is important to analyze LifeMD's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact LifeMD's future performance. For an informed investment choice regarding LifeMD Stock, refer to the following important reports:Check out LifeMD Piotroski F Score and LifeMD Altman Z Score analysis. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of LifeMD. If investors know LifeMD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about LifeMD listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.64) | Revenue Per Share 4.847 | Quarterly Revenue Growth 0.383 | Return On Assets (0.21) | Return On Equity (7.82) |
The market value of LifeMD Inc is measured differently than its book value, which is the value of LifeMD that is recorded on the company's balance sheet. Investors also form their own opinion of LifeMD's value that differs from its market value or its book value, called intrinsic value, which is LifeMD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because LifeMD's market value can be influenced by many factors that don't directly affect LifeMD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between LifeMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if LifeMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LifeMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.